Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$133M |
| 2 |
AbbVie
ABBV
|
+$110M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$93.9M |
| 4 |
Amazon
AMZN
|
+$91.8M |
| 5 |
Otis Worldwide
OTIS
|
+$84M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$226M |
| 2 |
RTN
Raytheon Company
RTN
|
+$145M |
| 3 |
WBC
WABCO HOLDINGS INC.
WBC
|
+$51.2M |
| 4 |
Newmont
NEM
|
+$50.7M |
| 5 |
Yum! Brands
YUM
|
+$33.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.6% |
| 2 | Healthcare | 15.16% |
| 3 | Consumer Discretionary | 12.49% |
| 4 | Communication Services | 10.41% |
| 5 | Industrials | 8.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PPBI
1251
DELISTED
Pacific Premier Bancorp
PPBI
| $4.14M | ﹤0.01% |
190,857
+86,583
| +83% | +$1.74M |
|
1252
Under Armour
UAA
$2.3B
| $4.13M | ﹤0.01% |
424,426
-299,600
| -41% | -$2.84M |
|
|
MANT
1253
DELISTED
Mantech International Corp
MANT
| $4.13M | ﹤0.01% |
60,287
+8,100
| +16% | +$596K |
|
1254
Hancock Whitney
HWC
$6.34B
| $4.13M | ﹤0.01% |
194,700
+25,600
| +15% | +$528K |
|
1255
Ligand Pharmaceuticals
LGND
$5.76B
| $4.12M | ﹤0.01% |
58,990
+4,328
| +8% | +$274K |
|
1256
Workiva
WK
$3.7B
| $4.12M | ﹤0.01% |
76,921
+14,600
| +23% | +$598K |
|
|
DOOR
1257
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $4.11M | ﹤0.01% |
52,877
+4,600
| +10% | +$279K |
|
1258
First Majestic Silver
AG
$9.26B
| $4.1M | ﹤0.01% |
414,700
+53,500
| +15% | +$453K |
|
1259
Atlantic Union Bankshares
AUB
$6.09B
| $4.1M | ﹤0.01% |
176,847
+35,400
| +25% | +$797K |
|
1260
Sunstone Hotel Investors
SHO
$2.01B
| $4.1M | ﹤0.01% |
502,549
+66,600
| +15% | +$578K |
|
1261
Corcept Therapeutics
CORT
$12.1B
| $4.09M | ﹤0.01% |
243,100
+43,600
| +22% | +$613K |
|
1262
Badger Meter
BMI
$3.91B
| $4.08M | ﹤0.01% |
64,900
+8,400
| +15% | +$498K |
|
1263
Monro
MNRO
$359M
| $4.08M | ﹤0.01% |
74,342
+9,800
| +15% | +$522K |
|
|
DOO
1264
Bombardier Recreational Products
DOO
$4.69B
| $4.08M | ﹤0.01% |
96,300
+13,000
| +16% | +$389K |
|
|
ELME
1265
Elme Communities
ELME
$144M
| $4.07M | ﹤0.01% |
183,300
+27,000
| +17% | +$601K |
|
|
SUM
1266
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $4.07M | ﹤0.01% |
257,259
+35,798
| +16% | +$513K |
|
1267
Healthcare Services Group
HCSG
$1.43B
| $4.06M | ﹤0.01% |
166,063
+22,300
| +16% | +$528K |
|
1268
SPX Corp
SPXC
$10.9B
| $4.06M | ﹤0.01% |
98,718
+13,200
| +15% | +$497K |
|
1269
AeroVironment
AVAV
$9.59B
| $4.05M | ﹤0.01% |
50,900
+9,000
| +21% | +$580K |
|
|
PRO
1270
DELISTED
PROS Holdings
PRO
| $4.05M | ﹤0.01% |
91,200
+16,900
| +23% | +$597K |
|
1271
Olin
OLN
$2.13B
| $4.05M | ﹤0.01% |
352,132
+42,500
| +14% | +$541K |
|
1272
Editas Medicine
EDIT
$432M
| $4.04M | ﹤0.01% |
136,500
+47,000
| +53% | +$1.23M |
|
|
CVET
1273
DELISTED
Covetrus, Inc. Common Stock
CVET
| $4.03M | ﹤0.01% |
225,240
+29,500
| +15% | +$388K |
|
1274
Ryman Hospitality Properties
RHP
$7.82B
| $4.03M | ﹤0.01% |
116,400
+21,600
| +23% | +$717K |
|
1275
Albany International
AIN
$1.81B
| $4.02M | ﹤0.01% |
68,500
+9,000
| +15% | +$487K |
|
Similar funds
Swiss National Bank's Q2 2020 Portfolio in Review
As of Q2 2020, Swiss National Bank held 2,599 positions worth $118B, up 26% from $94.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Swiss National Bank's Q2 2020 filing shows 119 new, 2,134 increased, 181 reduced and 161 closed positions. Its largest new stake was Otis Worldwide: 1,621,054 shares worth $92.2M. The largest sale was Allergan plc, an estimated $226M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q2 2020 buy was Otis Worldwide: 1,621,054 shares worth $92.2M.
- Swiss National Bank added most to Alibaba in Q2 2020, an estimated $133M increase.
- Swiss National Bank's biggest Q2 2020 reduction was Newmont, cutting an estimated $50.7M.
- Swiss National Bank fully exited Allergan plc in Q2 2020, selling an estimated $226M.
- Swiss National Bank's ten largest holdings make up 24% of its $118B portfolio in Q2 2020.
- Swiss National Bank opened 119 new positions and closed 161 in Q2 2020.
- Swiss National Bank's portfolio value rose 26% quarter-over-quarter to $118B.
Based on Swiss National Bank's 13F filing for Q2 2020, filed 5 Aug 2020.